What one share of Autonomix Medical holds
We are a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Our platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (“RF”) ablation, enabling a “sense, treat, verify” approach intended to improve the precision and consistency of nerve-targeted therapies.
Autonomix Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$36.40 |
| Cash and investments | $6.38 |
| Book value | $5.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.00 | −$311.27 | $0.38 | −$133.56 | — | $169.95 |
| 2025 | $0.00 | −$135.65 | $0.17 | −$98.34 | — | $68.11 |
| 2026 | $0.00 | −$48.64 | $0.03 | −$35.77 | — | $10.85 |
Common questions about Autonomix Medical
How much does one share of Autonomix Medical earn?
Over the last 12 months, Autonomix Medical lost $36.40 for each share.
Does Autonomix Medical pay a dividend?
Autonomix Medical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Autonomix Medical’s book value per share?
Autonomix Medical’s book value is $5.83 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Autonomix Medical have?
Each share of Autonomix Medical has $6.38 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.